News

Published on 15 Mar 2024 on Investing.com

Immuneering stock price target cut to $16 from $21

Article preview image

On Friday, Chardan Capital Markets adjusted its price target forImmuneering Corporation (NASDAQ:IMRX), a biopharmaceutical company, reducing it to $16.00...

Read the rest of the article
NASDAQ.IMRX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Immuneering Leads The Pack Of 3 US Penny Stocks To Consider

As the S&P 500 nears record highs, fueled by a surge in AI stocks and robust earnings reports,...

Simply Wall St. · via Yahoo Finance 23 Jan 2025
Immuneering Leads The Pack Of 3 US Penny Stocks To Monitor

As the U.S. stock market experiences a positive uptick with major indices like the Dow Jones and ...

Simply Wall St. · via Yahoo Finance 22 Nov 2024
Why Is Nanocap Immuneering Stock Trading Higher On Friday?

On Thursday, Immuneering Corporation (NASDAQ:IMRX) released initial response data from the first...

Benzinga · via Yahoo Finance 22 Sep 2024
Immuneering Director Acquires 7.5% More Stock

Potential Immuneering Corporation (NASDAQ:IMRX) shareholders may wish to note that the Director, ...

Simply Wall St. via Yahoo Finance 21 Mar 2024
Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks...

Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stock...

Investing.com 18 Mar 2024
Immuneering (IMRX) Plummets 71% in One Week: Here's Why

Immuneering Corporation IMRX is a clinical-stage biotech company focused on developing universal-...

Zacks via Yahoo Finance 18 Mar 2024
Cancer Treatment Focused Immuneering Faces Analyst Downgrades, Who Cite Underwhelming Solid Tumor...

Thursday, Immuneering Corporation IMRX revealed topline results from the ongoing Phase 1 portion ...

Benzinga 15 Mar 2024
Crude Oil Edges Lower; US Consumer Sentiment Falls In March - Cardlytics (NASDAQ:CDLX), American...

U.S. stocks traded lower midway through trading, with the Dow Jones index falling over 100 points...

Benzinga 15 Mar 2024
Immuneering stock downgraded by Jefferies on Lackluster Phase 1 Data By Investing.com

Immuneering stock downgraded by Jefferies on Lackluster Phase 1 Data

Investing.com 15 Mar 2024
Immuneering stock target cut to $15 by Needham

Immuneering stock target cut to $15 by Needham

Investing.com 15 Mar 2024

Copyright Statfolio @ 2025

Social Accounts